SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-378266
Filing Date
2012-09-04
Accepted
2012-09-04 07:51:35
Documents
3
Period of Report
2012-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d406259d8k.htm 8-K 25397
2 AGREEMENT AND PLAN OF MERGER d406259dex21.htm EX-2.1 398457
3 COMMITMENT LETTER d406259dex101.htm EX-10.1 118974
  Complete submission text file 0001193125-12-378266.txt   544164
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 121069644
SIC: 2834 Pharmaceutical Preparations